METTL3 and cancer: It is known that METTL3 may also have other functions besides its catalytic activity in cancers, and cytoplasmic‐localized METTL3 was proposed as a potential m6A reader.[93, 165] Thus, development of inhibitors to target special RNA m6A methyltransferase has good application prospects in future studies.